Nav: Home

BrightFocus Foundation honors 5 researchers on macular degeneration and glaucoma

May 02, 2016

SEATTLE, WA, May 2, 2016 -- BrightFocus Foundation today recognized five scientists in the fields of macular degeneration and glaucoma research, awarding them grants named in honor of leaders in vision research and advocacy.

The five recognized today are among a group of 32 scientists who will collectively receive nearly $5 million in vision research grants this year from BrightFocus, a record level of financial support. The awards were presented at a Seattle breakfast event coinciding with the annual meeting of the Association for Research in Vision and Ophthalmology.

"We are proud to honor and support these brilliant scientists as they strive to better understand and ultimately end macular degeneration and glaucoma. Their innovative work honors the legacies of the advocates and scientists in whose name these awards are given," said BrightFocus President and CEO Stacy Haller.

The five scientists honored today with named awards, all women, come from research institutions in four states in the US--California, Maryland, Massachusetts, and Ohio--and from Australia. The awards are as follows:

Macular Degeneration Research

  • Vera Bonilha, PhD, of The Cleveland Clinic Foundation, received The Elizabeth Anderson Award for Macular Degeneration Research, to better understand late-stage dry, age-related macular degeneration (AMD) by comparing images of eyes donated by persons with AMD, with a detailed analysis of the changes in inflammation and cell structure along the leading edge of retinal lesions.

  • Maria Valeria Canto-Soler, PhD, of Johns Hopkins University, received The Helen Juanita Reed Award for Macular Degeneration Research, to develop a novel 3D human mini-retina model ("retina in a dish") for the early stages of macular degeneration, to help investigate the initial triggers leading to this disease.

  • Robyn Guymer, MBBS, PhD, of the Centre for Eye Research Australia, The University of Melbourne, received The Carolyn K. McGillvray Award for Macular Degeneration Research, to study the underlying mechanisms by which debris accumulates in the retina in AMD, a process that may lead to novel treatments for early AMD.

Glaucoma Research

  • Meredith Gregory-Ksander, PhD, of the Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, received The Thomas R. Lee Award for Glaucoma Research, to test whether inhibiting an important new regulator of inflammation in the eye's optic nerve head will stop the development of glaucoma and vision loss.

  • Yvonne Ou, MD, of the University of California, San Francisco, received The Dr. Douglas H. Johnson Award for Glaucoma Research, to better understand the steps between optic nerve cell injury, loss of nerve cell connections, and cell death in glaucoma -- an understanding that could ultimately lead to treatments before irreversible cell death occurs.

The names and projects of this year's other individual grant recipients will be announced at a later date, pending completion of final agreements with researchers and supporting institutions.
-end-
The nonprofit BrightFocus Foundation drives innovative research worldwide and promotes public awareness of Alzheimer's, macular degeneration, and glaucoma. For more information, call 1-800-437-2423 or visit http://www.BrightFocus.org.

BrightFocus Foundation

Related Glaucoma Articles:

Long-term statin use associated with lower glaucoma risk
A new study brings the connection between statin use and risk of glaucoma into sharper focus.
Health burden of glaucoma has risen worldwide
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study.
UAlberta scientists first to pinpoint a cause of pigmentary glaucoma
An international team of researchers has identified a gene responsible for the onset of pigmentary glaucoma, which may lead to new therapies for the condition.
Using EHR-linked medication reminders for glaucoma patients
Mobile device reminders have been associated with better medication adherence and linking reminders to patient electronic health records (EHRs) could potentially allow some oversight by clinicians.
Traditional glaucoma test can miss severity of disease
The most common test for glaucoma can underestimate the severity of the condition by not detecting the presence of central vision loss, also known as macular degeneration, according to a new Columbia University study.
Biomarkers facilitate early detection of glaucoma
Researchers at Ruhr-Universität Bochum have identified new potential biomarkers that may facilitate early detection of glaucoma in patients.
Study suggests glaucoma may be an autoimmune disease
A new study from MIT and Massachusetts Eye and Ear finds glaucoma may be an autoimmune disorder, mediated by T cells that target heat shock proteins in the retina.
Autoimmune response drives vision loss in glaucoma
A research team from Massachusetts Eye and Ear and MIT has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive vision loss from glaucoma, the second leading cause of irreversible blindness in the world.
Turmeric eye drops could treat glaucoma
A derivative of turmeric could be used in eye drops to treat the early stages of glaucoma, finds a new study led by UCL and Imperial College London researchers.
New glaucoma treatment could ease symptoms while you sleep
Eye drops developed by UBC researchers could one day treat glaucoma while you sleep -- helping to heal a condition that is one of the leading causes of blindness around the world.
More Glaucoma News and Glaucoma Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#540 Specialize? Or Generalize?
Ever been called a "jack of all trades, master of none"? The world loves to elevate specialists, people who drill deep into a single topic. Those people are great. But there's a place for generalists too, argues David Epstein. Jacks of all trades are often more successful than specialists. And he's got science to back it up. We talk with Epstein about his latest book, "Range: Why Generalists Triumph in a Specialized World".
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.